Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer

BACKGROUND: The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Surg Oncol
Päätekijät: Park, Chansub, Park, Kyeongmee, Kim, Jiyoung, Sin, Youngjoo, Park, Inseok, Cho, Hyunjin, Yang, Keunho, Bae, Byung Noe, Kim, Ki Whan, Ahn, Sookyung, Gwak, Geumhee
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5020449/
https://ncbi.nlm.nih.gov/pubmed/27619909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-0999-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia